Elevra Lithium (NASDAQ: ELVR) swings to profit as reserves and prices rise
Elevra Lithium Limited reports FY26 half-year results showing stronger pricing and merger-driven gains alongside operational challenges at its North American Lithium mine. Revenue rose to US$86M, up 8%, as the average realised spodumene price increased 34% to US$937/dmt despite concentrate production falling 7% to 96kt and sales down 20% to 92kt.
Underlying EBITDA improved to a small profit of US$1M from a US$(25)M loss, while profit after tax swung to US$74M, largely driven by a US$156M impairment reversal and merger-related accounting effects. Operating cash flow was a US$(28)M outflow after US$24M of merger costs, though NAL itself generated US$5M operating cash. Cash rose to US$81M helped by merger proceeds and equity issuance.
The completed merger of Sayona Mining and Piedmont Lithium created a larger North American hard-rock producer, with NAL Ore Reserves up 124% to 48.6Mt at 1.11% Li₂O and Moblan Mineral Resources up 30% to 121Mt at 1.19% Li₂O. Elevra kept FY26 guidance unchanged, targeting 180,000–190,000dmt of production, 170,000–190,000dmt of sales, unit operating costs of US$860–US$880/dmt sold, and US$26M of capital expenditure.
Positive
- Sharp turnaround in profitability: Profit after tax improved to US$74M from a US$(42)M loss, supported by higher realised prices, cost synergies and a US$156M impairment reversal at North American Lithium.
- Substantial reserve and resource growth: NAL Ore Reserves increased 124% to 48.6Mt at 1.11% Li₂O and Moblan Mineral Resources rose 30% to 121Mt at 1.19% Li₂O, strengthening long-term production potential.
- Improved pricing and cash position: Average realised selling price climbed 34% to US$937/dmt, while cash grew to US$81M, aided by NAL operating inflows, merger-related cash and equity proceeds.
- Merger synergies emerging: The completed Sayona–Piedmont merger delivered about US$5M of synergies in four months and simplified ownership at NAL, supporting a larger, more diversified platform.
Negative
- Operational underperformance at NAL: Spodumene concentrate production fell 7% to 96kt and sales dropped 20% to 92kt, with recovery impacted by higher iron and lower lithium grades in Phase 3 ore.
- Cost and cash flow pressure: Unit operating cost produced rose 14% to US$831/dmt, and the Group recorded US$(28)M operating cash outflow after US$24M of merger-related payments and a US$9M loss from Group operations.
- Short-term mining challenges: Higher strip ratios and ore-quality issues in the current mining phase are expected to persist in the near term, prompting an increase in full-year unit cost guidance to US$860–US$880/dmt sold.
Insights
Pricing strength, merger uplift and resource growth offset weaker production.
Elevra delivered an 8% revenue increase to US$86M even as spodumene concentrate production fell 7% and sales dropped 20%. The key driver was a 34% jump in average realised prices to US$937/dmt, helped by exiting a legacy offtake and optimising freight.
Operationally, North American Lithium faced lower grades and higher iron content from Phase 3, pushing unit operating cost produced up 14% to US$831/dmt. Yet unit cost sold declined 6% to US$814/dmt due to inventory effects, and NAL generated US$11M underlying EBITDA and US$5M operating cash.
The merger with Piedmont Lithium and reversal of prior NAL impairment produced a swing to US$74M profit after tax, but much of this was non-cash. Net cash from operations was a US$(28)M outflow after US$24M of merger costs. Maintaining FY26 guidance on production, costs and US$26M capex suggests management sees current mining challenges as temporary, though execution through Phase 3 and the NAL expansion will be crucial.
Expanded reserves and diversified assets enhance long-term growth platform.
Updated JORC estimates lifted NAL Ore Reserves 124% to 48.6Mt at 1.11% Li₂O and Resources to 95Mt at 1.15% Li₂O. Moblan’s Resource rose 30% to 121Mt at 1.19% Li₂O, with 89% in Measured and Indicated categories, reinforcing its scale and quality.
These larger ore bodies underpin Elevra’s NAL brownfield expansion, where a scoping study outlined potential production of 315kt per year at a C1 cash cost of US$630/t, and an accelerated, staged pathway could bring full capacity around two years earlier. Carolina Lithium permitting advances, including stormwater permits and an air permit application, broaden the future growth pipeline.
With US$81M cash, higher inventories and increased customer prepayments on the balance sheet, the company has more flexibility to fund studies and early works. However, advancing multiple large projects will still depend on market conditions, securing partnerships, and maintaining regulatory and community support, particularly in North Carolina and Quebec.
|
No.
|
Description
|
|
99.1
|
Announcement filed by the Registrant with the Australian Securities Exchange on February 20, 2026 – Carolina Lithium Town Hall Presentation.
|
|
99.2
|
Announcement filed by the Registrant with the Australian Securities Exchange on February 24, 2026 – Appendix 3H – Notification of Cessation of Securities.
|
|
99.3
|
Announcement filed by the Registrant with the Australian Securities Exchange on February 25, 2026 – Interim Financial Report for the Half Year Ended 31 December 2025.
|
|
99.4
|
Announcement filed by the Registrant with the Australian Securities Exchange on February 25, 2026 – FY26 Half Year Results.
|
|
99.5
|
Announcement filed by the Registrant with the Australian Securities Exchange on February 25, 2026 – FY26 Half Year Results Presentation.
|
|
ELEVRA LITHIUM LIMITED
|
||
|
Date: February 26, 2026
|
By:
|
/s/ Dylan Roberts
|
|
Name: Dylan Roberts
|
||
|
Title: Company Secretary and General Counsel
|
||







































![]() |
Appendix 3H - Notification of cessation of securities
|
|
ASX +security
code
|
Security description
|
Number of
+securities that
have ceased
|
The +securities have
ceased due to
|
Date of
cessation
|
||
|
|
||||||
|
ELVAM
|
PERFORMANCE RIGHTS
|
20,443
|
Lapse of conditional right to
securities because the
conditions have not been, or
have become incapable of
being, satisfied
|
20/02/2026
|
|
Appendix 3H - Notification of cessation of securities
|
1 / 4 |
![]() |
Appendix 3H - Notification of cessation of securities
|
|
1.2 Registered Number Type
|
Registration Number
|
|
ABN
|
26091951978
|
|
Appendix 3H - Notification of cessation of securities
|
2 / 4 |
![]() |
Appendix 3H - Notification of cessation of securities
|
| Date of cessation | Is the entity paying any consideration for the cessation? |
|
20/2/2026
|
No |
|
Lapse of 20,443 unlisted performance rights pursuant to the terms of the Company's Equity Incentive Plan.
|
|
Appendix 3H - Notification of cessation of securities
|
3 / 4 |
![]() |
Appendix 3H - Notification of cessation of securities
|
|
ASX +security code and description
|
Total number of
+securities on issue
|
|
ELV : ORDINARY FULLY PAID
|
169,376,771
|
|
ASX +security code and description
|
Total number of
+securities on issue
|
|
ELVAM : PERFORMANCE RIGHTS
|
2,733,008
|
|
ELVAN : OPTION EXPIRING 31-DEC-2028 EX $4.80
|
2,723,613
|
|
Appendix 3H - Notification of cessation of securities
|
4 / 4 |
















































![]() |
|
25 February 2026
|
| • |
Lithium recovery averaged 66%
and plant utilisation averaged 88% during the period. Temporary feed grade variability (grade and iron content) in the December 2025 quarter impacted recovery.
|
| • |
Updated Mineral Resource and Ore
Reserve estimates were completed at NAL1 and Moblan2, strengthening the quality and scale of Elevra’s portfolio and underpinning future growth pathways.
|
| • |
The North American Lithium (NAL)
Brownfield Expansion Scoping Study3 outlined a compelling economic case to materially increase production capacity at a reduced unit operating cost. A potential expansion was enabled by the merger of Sayona Mining and Piedmont Lithium which
created strategic alignment to advance the value-accretive expansion.
|
| • |
NAL produced 96,156 dry metric
tonnes (dmt) of spodumene concentrate during the FY26 half year, reflecting continued stable operations, with production 7% lower than the prior corresponding period (PCP) reflecting the impact of ore availability challenges which are of a
temporary nature rather than structural issues.
|
| • |
Spodumene concentrate sales
totalled 91,991 dmt across three shipments at an average realised price (FOB) of US$937 per dmt. Sales volumes were 20% lower than the PCP, primarily reflecting shipment timing.
|
| • |
Capital expenditure of US$12 million, with US$11 million related to the upgrade of the Tailings Storage Facility and other NAL optimisation and sustaining projects and US$1 million in growth capital largely focused on
advancing the NAL Brownfield Expansion.
|
| • |
Revenue of US$86 million generated by NAL was up 8% compared to the PCP as a 20% decline in spodumene concentrate tonnes sold was offset by a 34% increase
in average realised selling price.
|
| • |
Cost synergies generated by the merger of Sayona Mining and Piedmont Lithium totalled US$5 million for the four-month period as a merged Group, with the
majority of savings stemming from a reduction in Group general and administration costs. Annualised synergies remain on track with the target range of $15 million to $20 million.
|
|
INTERIM FINANCIAL REPORT • FY2026
|
1 |

| • |
Underlying EBITDA of US$1
million for the Group, including US$11 million in underlying EBITDA from NAL, was a $26 million improvement relative to the PCP as improved realised pricing offset higher corporate costs resulting from the merger.
|
| • |
Non-cash
extraordinary items totalled US$91 million, which includes a US$156 million reversal of the NAL impairment recognised in the year ended 30 June 2025. There were also US$8 million in extraordinary cash expenses for merger transaction costs,
which are now largely completed.
|
| • |
The Group
profit after income tax of US$74 million for the half year reflected a US$116 million increase from the PCP due to improved underlying EBITDA and benefit from extraordinary items.
|
| • |
Net cash
outflows from operating activities of US$28 million reflected an US$11 million cash profit from operations at NAL and US$5 million in operating cash flows, offset by one off outflows of US$24 million for merger transaction costs and a US$9
million cash loss from Group operations.
|
| • |
Closing cash balance of US$81 million was US$34 million higher than the end of June 2025, underpinning a solid financial position with no secured debt.
|
|
INTERIM FINANCIAL REPORT • FY2026
|
2 |


|
Unit
|
H1 FY26
|
H1 FY25
|
Variance
|
|
|
North American Lithium5
|
||||
|
Ore mined
|
wmt
|
728,142
|
610,683
|
19%
|
|
Recovery
|
%
|
66
|
67
|
(1%)
|
|
Concentrate produced
|
dmt
|
96,156
|
103,063
|
(7%)
|
|
Concentrate grade produced
|
%
|
5.1
|
5.3
|
(0.2%)
|
|
Concentrate sold
|
dmt
|
91,991
|
115,027
|
(20%)
|
|
Average realised selling price (FOB)6
|
US$/dmt
|
937
|
697
|
34%
|
|
Unit operating cost sold (FOB)7
|
US$/dmt
|
814
|
861
|
(6%)
|
|
Group5
|
||||
|
Revenue
|
US$M
|
86
|
80
|
8%
|
|
Underlying EBITDA profit / (loss)
|
US$M
|
1
|
(25)
|
103%
|
|
Profit / (loss) after income tax
|
US$M
|
74
|
(42)
|
276%
|
|
Net cashflow from operating activities
|
US$M
|
(28)
|
12
|
(328%)
|
|
Cash balance
|
US$M
|
81
|
69
|
18%
|
|
INTERIM FINANCIAL REPORT • FY2026
|
3 |

|
INTERIM FINANCIAL REPORT • FY2026
|
4 |

|
INTERIM FINANCIAL REPORT • FY2026
|
5 |

|
INTERIM FINANCIAL REPORT • FY2026
|
6 |


|
Unit
|
Guidance
|
|
|
Spodumene concentrate production
|
dmt
|
180,000 - 190,000
|
|
Spodumene concentrate sales
|
dmt
|
170,000 - 190,000
|
|
Unit operating cost sold
|
US$/dmt
|
US$860 – US$880
|
|
Capital expenditures
|
US$M
|
US$26
|
|
INTERIM FINANCIAL REPORT • FY2026
|
7 |

|
INTERIM FINANCIAL REPORT • FY2026
|
8 |

|
US$’000
|
H1 FY26
|
H1 FY25
|
Variance
|
|
Underlying EBITDA
|
779
|
(24,908)
|
103%
|
|
Underlying depreciation and amortisation expense
|
(6,802)
|
(14,607)
|
53%
|
|
Underlying earnings adjustments
|
|||
|
Gain on bargain purchase
|
62,928
|
—
|
—
|
|
Income from sale of tax benefits under flow through share arrangements
|
—
|
4,020
|
—
|
|
Net movement in inventories relating to net realisable value adjustments
|
9,429
|
2,518
|
274%
|
|
Reversal of impairment of non-financial assets
|
155,599
|
—
|
—
|
|
Merger transaction and integration costs
|
(8,292)
|
(3,427)
|
(142%)
|
|
Write down of acquired contractual rights on business combination
|
(137,000)
|
—
|
—
|
|
Profit/(loss) from operations
|
76,641
|
(36,404)
|
311%
|
|
Net financial expense
|
(2,066)
|
(829)
|
(149%)
|
|
Income tax expense
|
(634)
|
(4,859)
|
87%
|
|
Profit/(loss) after income tax
|
73,941
|
(42,092)
|
276%
|

|
INTERIM FINANCIAL REPORT • FY2026
|
9 |

























FAQ
How did Elevra Lithium (ELVR) perform financially in H1 FY26?
What were Elevra Lithium (ELVR)’s production and sales volumes in H1 FY26?
How are Elevra Lithium (ELVR)’s unit costs and realised prices trending?
What impact did the Sayona–Piedmont merger have on Elevra Lithium (ELVR)?
How strong are Elevra Lithium (ELVR)’s reserves and resources after recent updates?
What FY26 guidance has Elevra Lithium (ELVR) provided for production and costs?
How is Elevra Lithium (ELVR) positioned for long-term growth in lithium markets?
Filing Exhibits & Attachments
5 documents

